Rocky L. Baker

1.7k total citations · 1 hit paper
26 papers, 1.3k citations indexed

About

Rocky L. Baker is a scholar working on Genetics, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Rocky L. Baker has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 17 papers in Surgery and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Rocky L. Baker's work include Diabetes and associated disorders (21 papers), Pancreatic function and diabetes (17 papers) and Diabetes Management and Research (12 papers). Rocky L. Baker is often cited by papers focused on Diabetes and associated disorders (21 papers), Pancreatic function and diabetes (17 papers) and Diabetes Management and Research (12 papers). Rocky L. Baker collaborates with scholars based in United States, Canada and Belgium. Rocky L. Baker's co-authors include Kathryn Haskins, Thomas Delong, Brenda Bradley, Gene Barbour, Timothy A. Wiles, Roger Powell, Nichole Reisdorph, Richard Reisdorph, Michael Armstrong and Maki Nakayama and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Rocky L. Baker

24 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion

2016 379 citations Thomas Delong, Timothy A. Wiles et al. Science profile →

Peers

Countries citing papers authored by Rocky L. Baker

Since Specialization

Citations

This map shows the geographic impact of Rocky L. Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocky L. Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocky L. Baker more than expected).

Fields of papers citing papers by Rocky L. Baker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rocky L. Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocky L. Baker. The network helps show where Rocky L. Baker may publish in the future.

Co-authorship network of co-authors of Rocky L. Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Rocky L. Baker. A scholar is included among the top collaborators of Rocky L. Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocky L. Baker. Rocky L. Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel T-Cell Reactivities to Hybrid Insulin Peptides in Islet Autoantibody–Positive At-Risk Individuals 2025 ·Diabetes ·Anita C. Hohenstein, (unknown), Mylinh Dang, (unknown), (unknown), (unknown), Kathleen Waugh, Fran Dong, Eddie A. James, Cate Speake, Andrea K. Steck, Marian Rewers, Peter A. Gottlieb, Kathryn Haskins, Thomas Delong, Rocky L. Baker	0
2	Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice 2025 ·Diabetes ·(unknown), (unknown), K. M. Nicholson, Mylinh Dang, Janet M. Wenzlau, (unknown), Anita C. Hohenstein, Roger Powell, Rocky L. Baker, Kathryn Haskins, Jennifer L. Matsuda, Thomas Delong	0
3	An Insulin-Chromogranin A Hybrid Peptide Activates DR11-Restricted T Cells in Human Type 1 Diabetes 2024 ·Diabetes ·(unknown), (unknown), Rocky L. Baker, (unknown), Anita C. Hohenstein, Peter A. Gottlieb, Chantal Mathieu, Lut Overbergh, Kathryn Haskins, Eddie A. James	4
4	Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes 2022 ·Frontiers in Immunology ·Janet M. Wenzlau, (unknown), Gene Barbour, Mylinh Dang, Anita C. Hohenstein, Maki Nakayama, Thomas Delong, Rocky L. Baker, Kathryn Haskins	11
5	Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes 2022 ·Diabetes ·(unknown), Timothy A. Wiles, Janet M. Wenzlau, Roger Powell, Gene Barbour, Mylinh Dang, (unknown), (unknown), (unknown), Anita C. Hohenstein, Rocky L. Baker, Hubert M. Tse, Kathryn Haskins, Thomas Delong	33
6	Chromogranin A Deficiency Confers Protection From Autoimmune Diabetes via Multiple Mechanisms 2021 ·Diabetes ·Neetu Srivastava, Hao Hu, Anthony N. Vomund, (unknown), Rocky L. Baker, (unknown), Luc Teyton, Xiaoxiao Wan, Emil R. Unanue	9
7	Soluble Antigen Arrays Efficiently Deliver Peptides and Arrest Spontaneous Autoimmune Diabetes 2021 ·Diabetes ·(unknown), Stephanie N. Johnson, Martin A. Leon, Mohsen Khosravi‐Maharlooei, Rocky L. Baker, (unknown), Cory Berkland, Rémi J. Creusot	13
8	Nanoparticles Containing an Insulin–ChgA Hybrid Peptide Protect from Transfer of Autoimmune Diabetes by Shifting the Balance between Effector T Cells and Regulatory T Cells 2019 ·The Journal of Immunology ·(unknown), Tobias Neef, Andrew Goodspeed, Brenda Bradley, Rocky L. Baker, Stephen D. Miller, Kathryn Haskins	58
9	Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes 2019 ·Diabetes ·Rocky L. Baker, Marynette Rihanek, Anita C. Hohenstein, Maki Nakayama, Aaron W. Michels, Peter A. Gottlieb, Kathryn Haskins, Thomas Delong	68
10	Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetes 2019 ·Current Opinion in Endocrinology Diabetes and Obesity ·Rocky L. Baker, (unknown), Kathryn Haskins	19
11	Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion breakdown → 2016 ·Science ·Thomas Delong, Timothy A. Wiles, Rocky L. Baker, Brenda Bradley, Gene Barbour, Richard Reisdorph, Michael Armstrong, Roger Powell, Nichole Reisdorph, Nitesh Kumar, Colleen M. Elso, Megan DeNicola, Rita Bottino, Alvin C. Powers, David M. Harlan, Sally C. Kent, Stuart I. Mannering, Kathryn Haskins	379
12	An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse 2016 ·Journal of Autoimmunity ·Timothy A. Wiles, Thomas Delong, Rocky L. Baker, Brenda Bradley, Gene Barbour, Roger Powell, Nichole Reisdorph, Kathryn Haskins	75
13	Cutting Edge: Nonobese Diabetic Mice Deficient in Chromogranin A Are Protected from Autoimmune Diabetes 2015 ·The Journal of Immunology ·Rocky L. Baker, Brenda Bradley, Timothy A. Wiles, Robin S. Lindsay, Gene Barbour, Thomas Delong, Rachel S. Friedman, Kathryn Haskins	40
14	The T Cell Repertoire–Diversifying Enzyme TSSP Contributes to Thymic Selection of Diabetogenic CD4 T Cell Specificities Reactive to ChgA and IAPP Autoantigens 2015 ·The Journal of Immunology ·Christophe Viret, (unknown), Rocky L. Baker, Kathryn Haskins, Sylvie Guerder	14
15	Chromogranin A is a T cell antigen in human type 1 diabetes 2013 ·Journal of Autoimmunity ·Peter A. Gottlieb, Thomas Delong, Rocky L. Baker, Lisa Fitzgerald-Miller, R. Wagner, (unknown), Marian Rewers, Aaron W. Michels, Kathryn Haskins	67
16	T cells interact with T cells via CD40‐CD154 to promote autoimmunity in type 1 diabetes 2012 ·European Journal of Immunology ·Rocky L. Baker, Thierry Mallevaey, Laurent Gapin, Kathryn Haskins	15
17	Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes 2012 ·Immunologic Research ·Thomas Delong, Rocky L. Baker, Jing He, Kathryn Haskins	15
18	Diabetogenic T-Cell Clones Recognize an Altered Peptide of Chromogranin A 2012 ·Diabetes ·Thomas Delong, Rocky L. Baker, Jing He, Gene Barbour, Brenda Bradley, Kathryn Haskins	90
19	Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts 2010 ·Proceedings of the National Academy of Sciences ·Kathryn J. Potter, Andisheh Abedini, Peter Marek, Agnieszka Klimek‐Abercrombie, Sonia A. Butterworth, (unknown), Rocky L. Baker, Melanie R. Nilsson, Garth L. Warnock, José Oberholzer, Suzanne Bertera, Massimo Trucco, Gregory S. Korbutt, Paul E. Fraser, Daniel P. Raleigh, C. Bruce Verchere	146
20	CD40 on NOD CD4 T cells contributes to their activation and pathogenicity 2008 ·Journal of Autoimmunity ·Rocky L. Baker, David H. Wagner, Kathryn Haskins	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact